In UTAR, I have been able to learn all the necessary fundamental knowledge to maintain and differentiation stem cells/ iPSC/ cancer in a short 6 months’ time despite interruption from CoV- 19. In NYCU, I continued to establish iMSC differentiation from iPSC, then further conduct analysis and assay with the resources here. I can utilize the facilities (Confocal Microscope, Flow cytometry and Single-Cell processing facilities and sequencing) with ease as I have prior knowledge and experience, I have gathered in UTAR. I had the opportunity to also carry out in- depth analysis using next generation sequencing and organoid technology together with new knowledge to learn from colleagues and friends in NYCU. With adequate resources in NYCU, I am also able to conduct experiments and assays, that allows me to explore and expose myself to more conditions and treatment for my project so that I can have a more detailed analysis on how the stroma environment can really affect the NSCLC. This 1-year experience in both UTAR and NYCU has allowed me to conduct more in-depth research as well as be able to experience two research cultures which is very enriching and fulfilling.
Top Left: Took picture with Dr Lotus Wang Mong Lien from NYCU
Top Right: Took picture with my external co-supervisor, Prof Dr Chiou Shih Hwa from NYCU
Bottom: View of culture room